Literature DB >> 12508334

The Japanese version of the Multiple Affect Adjective Checklist-Revised: development and validation.

Tomoyuki Yasuda1, Bernard Lubin, Juhu Kim, Rodney Van Whitlock.   

Abstract

In order to develop a Japanese version of the Multiple Affect Adjective Checklist-Revised (MAACL-R), the 66 scored adjectives were translated into Japanese and translated back into English as recommended by Werner and Campbell (1971). Confirmatory factor analyses evidenced the existence of five first-order factors (i.e., the anxiety, depression, hostility, positive affect, and sensation-seeking factors) and the two second-order factors (i.e., the dysphoric and pleasant affect factors) underlying the response to the Japanese MAACL-R. Internal consistency ranged from .73 to .91, and four-week retest reliability ranged from .67 to .74 on the seven scales (Anxiety, Depression, Hostility, Positive Affect, Sensation Seeking, Dysphoria, and PASS). Although correlations with the scales of the State-Trait Personality Inventory, State-Trait Anxiety Inventory, Center for Epidemiologic Studies Depression scale, a sensation-seeking scale, and a subjective well-being scale indicated only acceptable discriminant validity, adequate convergent validity was evidenced by the examination of these correlations. The Japanese version of the MAACL-R seems to be ready for use in research. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12508334     DOI: 10.1002/jclp.10120

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  2 in total

1.  The Clinical Ethnographic Interview: a user-friendly guide to the cultural formulation of distress and help seeking.

Authors:  Denise Saint Arnault; Shizuka Shimabukuro
Journal:  Transcult Psychiatry       Date:  2011-12-22

2.  Adolescents' Psychological Well-Being: A Multidimensional Measure.

Authors:  Carmen Viejo; Mercedes Gómez-López; Rosario Ortega-Ruiz
Journal:  Int J Environ Res Public Health       Date:  2018-10-22       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.